Synoptics Health Appoints Ultra Clean as US Distributor for ProReveal Fluorescence Protein Detection Test for Detecting Residual Proteins On Surgical Instruments

Synoptics Health, a manufacturer of innovative digital imaging systems for healthcare applications, is pleased to announce the appointment of industry leading surgical instrument cleaning firm, Ultra Clean Systems, Inc as its North American distributor of the ultra-sensitive ProReveal Protein Detection Test.

  • Share on TwitterShare on FacebookShare on Google+Share on LinkedInEmail a friend

Cambridge, UK (PRWEB) June 20, 2014

Ultra Clean Systems will distribute and support Synoptic Health’s ProReveal Protein Detection Test (a rapid and ultra-sensitive fluorescence technique that detects microgram levels of residual protein remaining on surgical instruments after the washer disinfector process) through its extensive support network across North America. This agreement will allow Sterile Services Departments (SSDs) throughout the country to assess the ProReveal technology on site and accurately discover how well their own surgical instrument decontamination processes perform.

The ProReveal Test uses fluorescence to detect microgram amounts of protein on surgical instruments and is the only commercial test on the market which complies with new recommendations for preventing iatrogenic vCJD infections.

ProReveal offers a highly sensitive alternative to swabbing techniques and tests the whole instrument for protein, rather than just a small, swabbed area. Taking less than 5 minutes to carry out, ProReveal generates results as a visual display of the presence (or absence) of any protein and these results can be documented and archived as proof of process cleanliness. Since the test is both visual and quantifiable, ProReveal provides confidence that decontamination processes are performing to the correct standards.

Paul Ellwood, Synoptics Health’s CEO said: “As the demand for our unique ProReveal Test has increased throughout the US, Ultra Clean Systems with its infrastructure and extensive experience of surgical instrument decontamination in US SSDs represents an ideal partner for supporting and maximizing the growth of our revolutionary residual protein detection technology.”

Paul continued: “We are confident that Ultra Clean Systems will help US SSDs provide access to our unique ProReveal technology more easily. This will ensure decontamination processes are performing to the highest standard and keep patients safe from iatrogenic infections in many US hospitals.”

About Synoptics Health
Synoptics Health, based in Cambridge, UK is a division of the Synoptics Group of the AIM quoted Scientific Digital Imaging (SDI) Company based in Cambridge, UK. Synoptics is a world leader in the development and manufacture of innovative digital imaging systems for a range of life science applications. The Group includes three other divisions, Syngene, Syncroscopy, and Synbiosis.

About Ultra Clean Systems
Founded by O’Brien Cale in 1999, Oldsmar, Florida-based Ultra Clean Systems offers a leading range of ultrasonic cleaning systems for use in surgical environments. The company’s ultrasonic cleaning machines have been proven to remove more than 99% of harmful debris from laparoscopic instruments without the need for scrubbing and soaking. The Ultra Clean Systems product range includes a dual basin ultrasonic cleaner that remains the largest in the medical industry, a Robotic Arm Cleaning System (RACS) that is designed to flush both parts of da Vinci instruments, and the world’s first fully automated cleaning system with the capacity to clean 6 trays of instruments simultaneously.


Contact

  • Jayne Arthur
    Syngene.com
    +44 1223727113
    Email

Attachments

ProReveal fluorescence protein detection test ProReveal fluorescence protein detection test

ProReveal fluorescence protein detection test from Synoptics Health